Literature DB >> 6370666

Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture.

K K Huff, M E Lippman.   

Abstract

Activity of secreted plasminogen activator (PA) by ZR-75-1 human breast cancer cells in culture is shown to be altered by the addition of physiologically relevant concentrations of the hormones 17 beta-estradiol (E2), insulin, and dexamethasone. After 48 h, E2 stimulated PA activity 6-fold at concentrations as low as 10(-12) M. This stimulation was prevented by the addition of actinomycin D and cycloheximide. The antiestrogen tamoxifen reduced estrogen stimulation of PA, but had slight stimulatory effects on PA secretion by itself. Insulin (5 X 10(-10) M) induced a 2-fold increase in PA activity. Effects of insulin and E2 were additive, suggesting independent sites of control of PA production. Dexamethasone (10(-8) M) decreased PA activity by 20%, but did not inhibit cell growth at the concentration tested. These data suggest that secreted PA activity is differentially regulated by hormones and that effects of PA and growth do not occur in parallel.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6370666     DOI: 10.1210/endo-114-5-1702

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  S M Abidi; E W Howard; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

2.  Expression patterns of ER, HER2, and NM23-H1 in breast cancer patients with different menopausal status: correlations with metastasis.

Authors:  Su-Wei Dong; Lin Wang; Jun Sui; Xi-Yun Deng; Xiao-Dan Chen; Zhi-Wei Zhang; Xu Liu; Zhi-Min Liu; Jian-Hua Zhang; Qi-Sheng Yang; Yong-Feng Jia; Xin Song
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

3.  8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

Authors:  M E Lippman; R B Dickson; S Bates; C Knabbe; K Huff; S Swain; M McManaway; D Bronzert; A Kasid; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.

Authors:  I Tamm; I Cardinale; J S Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 5.  William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms.

Authors:  G Freiss; C Prébois; F Vignon
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.

Authors:  B S Katzenellenbogen; M A Miller; A Mullick; Y Y Sheen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.

Authors:  I Tamm; T Kikuchi; I Cardinale; J G Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.

Authors:  M Neeman; H Degani
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.

Authors:  A S Levenson; H C Kwaan; K M Svoboda; I M Weiss; S Sakurai; V C Jordan
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.